Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2a Trial of the PfSPZ Vaccine Administered Subcutaneously or Intradermally to Malaria-Naïve Adult Volunteers

NCT01001650 is registered in ClinicalTrials.gov with Sanaria Inc. as lead sponsor.

NCT NCT01001650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01001650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2a Trial of the PfSPZ Vaccine Administered Subcutaneously or Intradermally to Malaria-Naïve Adult Volunteers
Lead sponsor
Sanaria Inc.
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2009
Completion date
September 30, 2010
Enrollment
80 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

plasmodium falciparum